BeOne Medicines (ONC)
BeOne Medicines (ONC) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.
- ONC last traded at $390.94 on 2026-11-20, -2.19% for the session.
- BeOne Medicines: market cap $41.78B, P/E 45.6, revenue $6.61B over the last four quarters.
- Over the past year ONC returned 10.50%, with a year-to-date return of 28.68%.
ONC Slips as Broader Market News Stays Quiet
BeOne Medicines is down 1.2% today, while the S&P 500 is up 0.3% and the Nasdaq 100 is down 0.4%. No fresh company catalyst stands out; traders are weighing recent earnings and the outlook for its cancer-drug business.
Published 2026-11-20 15:01:04 UTC.